All news

Inspire Medical revenue falls 7.9% to $206.7 million on reimbursement trouble, narrows 2026 guide

GlobeNewswire · · AI-summarised by FinFlash

Inspire Medical Systems reported third-quarter revenue of $206.7 million, down 7.9%, citing coding and reimbursement challenges in the US. It swung to a net loss of $24.4 million, or 84 cents a share, against a 34-cent profit a year earlier, after $24.1 million of Project Horizon restructuring charges and a $7 million legal settlement. The sleep-apnea device maker narrowed its 2026 revenue forecast to $850 million to $860 million from $835 million to $875 million.

So What?

Reimbursement remains the key overhang for the stock until new CPT codes arrive in January 2028. A tighter guide reduces uncertainty, but the midpoint is unchanged at about $855 million.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.